Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Merrill

Showing results (301-310 of 414) with videos related to

Pageof 42
Sort By:
Arthritis Care & Research|April 19, 2022
Impact of Belimumab on Organ Damage in Systemic Lupus ErythematosusMurray B Urowitz, Cynthia Aranow, Yumi Asukai, et al.
Annals of the Rheumatic Diseases|September 14, 2010
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENAD A Isenberg, E Allen, V Farewell, et al.
Annals of Internal Medicine|June 22, 2005
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trialJill P Buyon, Michelle A Petri, Mimi Y Kim, et al.
Arthritis Care & Research|May 5, 2012
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisBevra H Hahn, Maureen A McMahon, Alan Wilkinson, et al.
The New England Journal of Medicine|December 16, 2005
Combined oral contraceptives in women with systemic lupus erythematosusMichelle Petri, Mimi Y Kim, Kenneth C Kalunian, et al.
Annals of the Rheumatic Diseases|December 21, 2023
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trialDi Wu, Jing Li, Dong Xu, et al.
JCI Insight|August 22, 2023
Ancestry-based differences in the immune phenotype are associated with lupus activitySamantha Slight-Webb, Kevin Thomas, Miles Smith, et al.
Arthritis and Rheumatism|August 1, 2009
A polymorphism within IL21R confers risk for systemic lupus erythematosusRyan Webb, Joan T Merrill, Jennifer A Kelly, et al.
Genes and Immunity|February 22, 2008
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African AmericansJ A Kelly, J M Kelley, K M Kaufman, et al.
Ophthalmology|November 6, 2020
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisEric B Suhler, Glenn J Jaffe, Eric Fortin, et al.
Pageof 42

Showing results (301-310 of 414) with videos related to

Sort By:
Pageof 42
Arthritis Care & Research|April 19, 2022
Impact of Belimumab on Organ Damage in Systemic Lupus ErythematosusMurray B Urowitz, Cynthia Aranow, Yumi Asukai, et al.
Annals of the Rheumatic Diseases|September 14, 2010
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENAD A Isenberg, E Allen, V Farewell, et al.
Annals of Internal Medicine|June 22, 2005
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trialJill P Buyon, Michelle A Petri, Mimi Y Kim, et al.
Arthritis Care & Research|May 5, 2012
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisBevra H Hahn, Maureen A McMahon, Alan Wilkinson, et al.
The New England Journal of Medicine|December 16, 2005
Combined oral contraceptives in women with systemic lupus erythematosusMichelle Petri, Mimi Y Kim, Kenneth C Kalunian, et al.
Annals of the Rheumatic Diseases|December 21, 2023
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trialDi Wu, Jing Li, Dong Xu, et al.
JCI Insight|August 22, 2023
Ancestry-based differences in the immune phenotype are associated with lupus activitySamantha Slight-Webb, Kevin Thomas, Miles Smith, et al.
Arthritis and Rheumatism|August 1, 2009
A polymorphism within IL21R confers risk for systemic lupus erythematosusRyan Webb, Joan T Merrill, Jennifer A Kelly, et al.
Genes and Immunity|February 22, 2008
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African AmericansJ A Kelly, J M Kelley, K M Kaufman, et al.
Ophthalmology|November 6, 2020
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisEric B Suhler, Glenn J Jaffe, Eric Fortin, et al.
Pageof 42